The impact of the type of insurance plan on adherence and persistence with antidepressants: A matched cohort study

Canadian Journal of Psychiatry

Volumn 58, Issue 4, 2013, Pages 233-239

  Assayag, Jonathan ^a   Forget, Amélie ^a   Kettani, Fatima Zohra ^a   Beauchesne, Marie France ^a   Moisan, Jocelyne ^b   Blais, Lucie ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Antidepressant agents; Health; Insurance; Medication adherence; Proportion of days covered; Proportion of prescribed days covered; Retrospective studies

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CANADA; CLINICAL EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIVATE HEALTH INSURANCE; PUBLIC HEALTH INSURANCE;

EID: 84878343182     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371305800409     Document Type: Article

References (28)

1. Beck CA, Patten SB, Williams JV, et al. Antidepressant utilization in Canada. Soc Psychiatry Psychiatr Epidemiol. 2005;40(10): 799-807.
2. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66(8): 848-856.
3. Dharmshaktu P, Tayal V, Kalra BS. Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol. 2012;52(1): 6-17.
4. Turgeon M, Guénette L, Gaudet M, et al. Conseil du médicament. Portrait de l'usage des antidépresseurs chez les adultes assurés par le régime public d'assurance médicaments du Québec. Quebec (QC): Gouvernement du Québec; 2011 [cited 2013 Jan 18]. Available from: http://www.inesss.qc.ca/fileadmin/ doc/CDM/Etudes/ CdM-Portrait-antidepresseurs-201101.pdf.
5. Patten SB, Williams JV, Mitton C. Costs associated with mood and anxiety disorders, as evaluated by telephone survey. Chronic Dis Can. 2008;28(4): 155-162.
6. Patten S, Juby H. Réseau canadien des Centres de données de recherche. Profil de la dépression clinique au Canada. Calgary (AB): University of Calgary; 2008 [cited 2013 Jan 18]. Available from: http://dspace.ucalgary.ca/bitstream/1880/46454/1/RSS1Profil%20 de%20la%20depression%20clinique%20au%20Canada.pdf.
7. Chen Y, Kelton CM, Jing Y, et al. Utilization, price, and spending trends for antidepressants in the US Medicaid Program. Res Social Adm Pharm. 2008;4(3): 244-257.
8. Davidson Jr. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry. 2010;71(Suppl E1):e04.
9. Bulloch AG, Patten SB. Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol. 2010;45(1): 47-56.
10. Sawada N, Uchida H, Suzuki T, et al. Persistence and compliance to antidepressant treatment in patients with depression: a chart review. BMC Psychiatry. 2009;9:38.
11. Akincigil A, Bowblis JR, Levin C, et al. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Med Care. 2007;45(4): 363-369.
12. Cantrell CR, Eaddy MT, Shah MB, et al. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care. 2006;44(4): 300-303.
13. Bambauer KZ, Soumerai SB, Adams AS, et al. Provider and patient characteristics associated with antidepressant nonadherence: the impact of provider specialty. J Clin Psychiatry. 2007;68(6): 867-873.
14. Tournier M, Moride Y, Crott R, et al. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population. J Affect Disord. 2009;115(1-2): 160-166.
15. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5): 487-497.
16. Caetano PA, Lam JM, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther. 2006;28(9): 1411-1424.
17. Gibson TB, Jing Y, Kim E, et al. Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients. Manag Care. 2010;19(8): 40-47.
18. Hodgkin D, Volpe-Vartanian J, Alegria M. Discontinuation of antidepressant medication among Latinos in the USA. J Behav Health Serv Res. 2007;34(3): 329-342.
19. Régie de l'assurance maladie du Québec. Annual statistics, 2006. Quebec (QC): Government of Quebec; 2007 [cited 2013 Jan 18]. Available from: http://www.ramq.gouv.qc.ca/ sitecollectiondocuments/citoyens/fr/rapports/ rappann0607-fr.pdf.
20. Blais L, Beauchesne MF, Lemiere C, et al. High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations. J Allergy Clin Immunol. 2009;124(6): 1229-1234.
21. Blais L, Kettani FZ, Perreault S, et al. Adherence to cholinesterase inhibitors in patients with Alzheimer's disease. J Am Geriatr Soc. 2009;57(2): 366-368.
22. Tamblyn R, Lavoie G, Petrella L, et al. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol. 1995;48(8): 999-1009.
23. Pando S, Lemiere C, Beauchesne MF, et al. Suboptimal use of inhaled corticosteroids in children with persistent asthma: inadequate prescription, poor drug adherence, or both? Pharmacotherapy. 2010;30(11): 1109-1116.
24. Blais L, Kettani FZ, Beauchesne MF, et al. New measure of adherence adjusted for prescription patterns: the case of adults with asthma treated with inhaled corticosteroid monotherapy. Ann Pharmacother. 2011;45(3): 335-341.
25. Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15(8): 565-574.
26. Sleath B, Domino ME, Wiley-Exley E, et al. Antidepressant and antipsychotic use and adherence among Medicaid youths: differences by race. Community Ment Health J. 2010;46(3): 265-272.
27. Kim YA, Loucks A, Yokoyama G, et al. Evaluation of value-based insurance design with a large retail employer. Am J Manag Care. 2011;17(10): 682-690.
28. Olfson M, Marcus SC, Tedeschi M, et al. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006;163(1): 101-108.